- Home
- ENSG vs RVMD Comparison
ENSG vs RVMD Comparison
Compare ENSG & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSG
- RVMD
- Stock Information
- Founded
- ENSG 1999
- RVMD 2014
- Country
- ENSG United States
- RVMD United States
- Employees
- ENSG N/A
- RVMD N/A
- Industry
- ENSG Hospital/Nursing Management
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ENSG Health Care
- RVMD Health Care
- Exchange
- ENSG Nasdaq
- RVMD Nasdaq
- Market Cap
- ENSG 8.9B
- RVMD 7.5B
- IPO Year
- ENSG 2007
- RVMD 2020
- Fundamental
- Price
- ENSG $141.18
- RVMD $37.81
- Analyst Decision
- ENSG Buy
- RVMD Strong Buy
- Analyst Count
- ENSG 7
- RVMD 13
- Target Price
- ENSG $164.71
- RVMD $68.38
- AVG Volume (30 Days)
- ENSG 315.4K
- RVMD 3.3M
- Earning Date
- ENSG 07-24-2025
- RVMD 08-06-2025
- Dividend Yield
- ENSG 0.18%
- RVMD N/A
- EPS Growth
- ENSG 39.72
- RVMD N/A
- EPS
- ENSG 5.30
- RVMD N/A
- Revenue
- ENSG $4,423,354,000.00
- RVMD N/A
- Revenue This Year
- ENSG $17.71
- RVMD N/A
- Revenue Next Year
- ENSG $9.87
- RVMD $226.82
- P/E Ratio
- ENSG $26.65
- RVMD N/A
- Revenue Growth
- ENSG 14.81
- RVMD N/A
- 52 Week Low
- ENSG $118.73
- RVMD $29.17
- 52 Week High
- ENSG $158.45
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- ENSG 35.31
- RVMD 46.33
- Support Level
- ENSG $143.72
- RVMD $36.37
- Resistance Level
- ENSG $151.74
- RVMD $38.97
- Average True Range (ATR)
- ENSG 2.81
- RVMD 1.34
- MACD
- ENSG -1.38
- RVMD 0.07
- Stochastic Oscillator
- ENSG 6.01
- RVMD 37.26
About ENSG The Ensign Group Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.